Luteal Phase Support Using Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone Supplementation in High Responders Following GnRHa Triggering - A Prospective Randomized Controlled Trial
Latest Information Update: 24 Aug 2023
Price :
$35 *
At a glance
- Drugs Estradiol (Primary) ; Nafarelin (Primary) ; Progesterone (Primary) ; Hydroxyprogesterone
- Indications Female infertility
- Focus Therapeutic Use
- 23 Mar 2021 New trial record